Compare Medtronic PLC (MDT) vs Novavax Inc (NVAX) Price & Performance

Medtronic PLCTrade

Novavax IncTrade

Price performance (Past 24H)

Key statistics

Medtronic PLC vs Novavax Inc — how do they compare? Medtronic PLC trades at $82.79 (market cap $106.61B), while Novavax Inc trades at $7.9 (market cap $1.30B). The key difference: Medtronic PLC is far larger — about 82× Novavax Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

	MDT	NVAX
Market Cap	$106.61B	$1.30B
Sector	Health	Health
52-Week High	$105.35	$11.19
52-Week Low	$73.75	$6.22
Enterprise Value	$125.36B	$800.50M
Dividend Yield	3.46%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MDT

Medtronic launches AI-powered Touch Surgery Aide for real-time support in robotic surgeries.PRNewsWire · 13 hours agoBullish Medtronic to report Q1 FY2027 financial results on September 1, 2026PRNewsWire · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

NVAX

View details →

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.